搜期刊
主题
文献检索

Investigational New Drugs PubMed AJ SCIE CA JST 中科院3区 JCR:Q2
发文量 4,414
被引量 82,443
影响因子(2023) 2.947

The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents. Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor. The journal also affords the opportunity to publish the proceedings of special workshops and symposia devoted to the development of new anticancer agents. Provided they add to the understanding of the investigational agents, the journal is not adverse to publishing clinical trials with negative results. Investigational New Drugs cuts across all the usual lines or subdisciplines, providing a locus for the presentation of relevant investigations and the discussion of critical questions appropriate to the entire field of new anticancer drug development. 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

  • 主办单位： SPRINGER
  • 出版周期： 双月刊
  • 别名： 创新性药物
  • 国际标准连续出版物号： ISSN 0167-6997
  • 创刊时间： 1983年
热门主题：

PatientsDoseTreatmenta PhaseGradeMetastaticPatientCancerToxicityPhase II TrialCellAPOPTOSISChemotherapySignificantCellsMedianPHARMACOKINETICSInhibitorActivityTherapy

收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
分析评价
  • 1
  • 2
  • 3
  • 4
  • 5
目录
封面
2024年06期
共：12篇

      不详

    • Gungordu, SeydaAptullahoglu, Erhan

      603-611
    • 612-622

    • Badawi, Mohamed AliEngelhardt, BenjaminDobkowska, EdytaDeng, RongKaufman, Jonathan L.Menon, RajeevSalem, Ahmed Hamed

      635-643

    • Begum, SalmaIrvin, Scheldon D.Cox, Carol K.Huang, ZhouyangWilson, Justin J.Monroe, Jerry D.Gibert, Yann

      644-654

    • Hamauchi, SatoshiYasui, HirofumiYokota, TomoyaTsushima, TakahiroFushiki, KunihiroNaito, TateakiOno, AkiraKado, NobuhiroOnozawa, YusukeMurakami, HaruyasuTakahashi, ToshiakiHirashima, YasuyukiMori, KeitaYamazaki, Kentaro

      655-663

    • Morisseau, MathildeGomezRoca, CarlosViala, MarieRabeau, AudreyLoirat, DelphineMunsch, NadiaThomas, KristellPages, CecileKorakis, IphigenieSibaud, VincentDelord, JeanPierreFilleron, ThomasCabarrou, Bastien

      664-674

    • Heath, Elisabeth I.Chen, WeiChoi, Jae E.Dobson, KimberleeSmith, MelanieMaj, TomaszKryczek, IlonaZou, WeipingChinnaiyan, Arul M.Qiao, Yuanyuan

      675-684

    • Zhang, XiaoxinDeng, JianhuaWu, RenjieHu, Jian

      685-693

    • Chen, ShaoshiZhong, QiZhang, ShurongZhang, YangHou, LizhenMa, HongzhiHe, ShizhiLian, MengHe, YurongWang, RuFang, Jugao

      694-702

    • Xu, ManyiWang, YanhuaWang, KeHao, YueXu, ChunweiShi, LeiSong, Zhengbo

      703-715

    • Jin, ZhaoCao, Yanshuo

      716-727

    • Na, JianrongLiu, YaqinFang, KunTan, YuanLiang, PanpanYan, MeiChu, JiaojiaoGao, JianmeiChen, DongshengZhang, Shuxiang

      728-738
2024年06期

2024年06期

客服咨询
投稿相关：023-63416211
撤稿相关：023-67396862
查重相关：023-63506028
重庆维普资讯有限公司 渝B2-20050021-1 渝公网备 50019002500403
违法和不良信息举报中心   举报邮箱：jubao@cqvip.com   互联网算法推荐专项举报：sfjubao@cqvip.com    网络暴力专项举报: bljubao@cqvip.com
网络出版：（署）网出证（渝）字第014号    出版物经营许可证：新出发2018批字第006号